HEIP
DGX icon

Hudson Edge Investment Partners’s Quest Diagnostics DGX Stock Holding History

Hudson Edge Investment Partners’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-31,700
Closed -$4.92M – 193
2024
Q3 		$4.92M Buy
31,700
+1,357
+4% +$203K 0.91% 48
2024
Q2 		$4.15M Sell
30,343
-10,399
-26% -$1.42M 0.8% 51
2024
Q1 		$5.42M Buy
40,742
+4,231
+12% +$549K 1.06% 44
2023
Q4 		$5.03M Buy
36,511
+977
+3% +$128K 1.17% 45
2023
Q3 		$4.33M Buy
35,534
+6,383
+22% +$850K 1.41% 44
2023
Q2 		$4.1M Buy
+29,151
New +$4.02M 1.3% 45

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Hudson Edge Investment Partners's DGX Position: Q4 2024 in Review

Hudson Edge Investment Partners sold out of Quest Diagnostics (DGX) in Q4 2024, closing a stake of 31,700 shares — an estimated $4.92M sold.

Hudson Edge Investment Partners first reported a position in DGX in Q2 2023 and held it in 6 quarters. The position peaked at $5.42M in Q1 2024. 895 funds tracked by Wall St. Rank hold DGX as of Q4 2024.

  • Hudson Edge Investment Partners reported no remaining Quest Diagnostics position as of Q4 2024 after selling out during the quarter.
  • Hudson Edge Investment Partners sold 31,700 Quest Diagnostics shares in Q4 2024, an estimated $4.92M.
  • Hudson Edge Investment Partners first reported a position in Quest Diagnostics in Q2 2023 and held it in 6 quarters.
  • Hudson Edge Investment Partners's Quest Diagnostics position peaked at $5.42M in Q1 2024.
  • 895 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2024.

Based on Hudson Edge Investment Partners's 13F filing for Q4 2024, filed 3 Feb 2025.